159 related articles for article (PubMed ID: 4173363)
1. Results of clinical trials of RhoGAM in women.
Pollack W; Gorman JG; Freda VJ; Ascari WQ; Allen AE; Baker WJ
Transfusion; 1968; 8(3):151-3. PubMed ID: 4173363
[No Abstract] [Full Text] [Related]
2. Long Beach (California) experience with Rh immunoglobulin.
Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
Transfusion; 1968; 8(3):146-8. PubMed ID: 4174356
[No Abstract] [Full Text] [Related]
3. Edinburgh (Scotland) experience with Rh immunoglobulin.
Robertson JG
Transfusion; 1968; 8(3):149-50. PubMed ID: 4173362
[No Abstract] [Full Text] [Related]
4. Liverpool experience with Rh immunoglobulin.
Finn R
Transfusion; 1968; 8(3):148-9. PubMed ID: 4173361
[No Abstract] [Full Text] [Related]
5. Immunologic suppression of primary Rh antibody formation.
Rosenfield RE
Transfusion; 1968; 8(3):125-6. PubMed ID: 4173359
[No Abstract] [Full Text] [Related]
6. Prevention of Rh-haemolytic disease.
Med J Aust; 1967 Aug; 2(6):261-2. PubMed ID: 4168760
[No Abstract] [Full Text] [Related]
7. Prevention of Rh immunization in Finland. A national study, 1969--1977.
Eklund J
Acta Paediatr Scand Suppl; 1978; (274):1-57. PubMed ID: 82366
[No Abstract] [Full Text] [Related]
8. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
Frey P; Hinselmann M; Hindemann P
Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764
[No Abstract] [Full Text] [Related]
9. Prevention of leucocyte-antibody formation.
Tovey GH; Darker CC
Lancet; 1970 Jun; 1(7661):1396-7. PubMed ID: 4195065
[No Abstract] [Full Text] [Related]
10. Rh immunization--experience with full-term pregnancies.
Freda VJ
Clin Obstet Gynecol; 1971 Jun; 14(2):594-610. PubMed ID: 4108163
[No Abstract] [Full Text] [Related]
11. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
Hindemann P; Hinselmann M; Frey P
Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
[No Abstract] [Full Text] [Related]
12. [Status of the prevention of the hemolytic disease of the newborn with gamma globulin in Switzerland].
de Muralt G; Stampfli K
Gynaecologia; 1969; 167(5):285-8. PubMed ID: 4184765
[No Abstract] [Full Text] [Related]
13. Anti-gamma-globulins in women treated with anti-Rh gamma-globulin.
Sturgeon P; Jennings ER
Transfusion; 1968; 8(6):343-7. PubMed ID: 4193845
[No Abstract] [Full Text] [Related]
14. [Use of immunoglobulin for prevention of Rh immunization].
Persianinov LS; Sidel'nikova VM; Umbrumiants DV
Akush Ginekol (Mosk); 1971 Dec; 47(12):3-6. PubMed ID: 4117942
[No Abstract] [Full Text] [Related]
15. Prevention of Rh-haemolytic disease: final results of the "high-risk" clinical trial. A combined study from centres in England and Baltimore.
Br Med J; 1971 Jun; 2(5762):607-9. PubMed ID: 4103276
[TBL] [Abstract][Full Text] [Related]
16. The immunology of Rh-haemolytic disease: a review.
Schiff P
Med J Aust; 1969 Nov; 2(18):915-9. PubMed ID: 4187850
[No Abstract] [Full Text] [Related]
17. [Prevention of maternal immunization to fetal antigen D].
Spensieri S; Storace A; Perasso F; Carnevale-Arella E; Bastiani G; De Geronimi GC
Minerva Ginecol; 1971 Mar; 23(5):234-50. PubMed ID: 4103431
[No Abstract] [Full Text] [Related]
18. [Immunoprophylaxis of neonatal hemolytic disease caused by Rh incompatibility. Analysis of a 5-year experience].
Sansone G; Veneziano G; Mantegazza F; Cominetti M
Pathologica; 1974; 66(961-962):477-89. PubMed ID: 4141760
[No Abstract] [Full Text] [Related]
19. Analysis of failures with Rh-immune globulin.
Gorman JG
Clin Obstet Gynecol; 1971 Jun; 14(2):635-46. PubMed ID: 4106516
[No Abstract] [Full Text] [Related]
20. [Our experiences in the prevention of Rh sensitization].
Mikulandra F; Kapitanović IM
Bilt Hematol Transfuz; 1975; 3(3):65-8. PubMed ID: 57776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
